Dermatology Marketing Portfolios 
The Dermatology Digest
DECEMBER 20, 2024
The post-market clinical study will assess Cohealyxs performance in real-world settings, focusing on clinical efficacy and cost savings in the treatment of full-thickness wounds and burns. FDA Clears Avita Medicals Cohealyx for Healing Full-thickness Wounds appeared first on The Dermatology Digest. The post U.S.
The Dermatology Digest
DECEMBER 18, 2024
“STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb). Our portfolio, supported by our fully integrated platform, establishes Celltrion USA as an important player in the U.S. immunology market.” Celltrion Inc. The post U.S.
The Dermatology Digest
NOVEMBER 12, 2024
The company has appointed Alex Haskell, MBA, as Vice President of Marketing, Sean Mathison as Vice President of Business Development & Innovation, Jonathan Nugent as Sales Director, and Olivia Swanson as Sales Director. Jonathan Nugent, Sales Director Mr. Nugent’s career includes roles at Medicis and Colgate-Palmolive.
The Dermatology Digest
FEBRUARY 21, 2025
The deal strengthens Cosettes dermatology and womens health businesses, expands Cosettes commercial and operational capabilities, and adds multiple sustainable and growing patent-protected products. The post Cosette Pharmaceuticals Acquires Mayne Pharma appeared first on The Dermatology Digest.
Southeastern Esthetics Institute
AUGUST 23, 2016
Specific courses for cosmetic lasers, for example, are crucial to add to the esthetics portfolio, in order to showcase added training beyond that of the esthetics fundamentals course. To be competitive in the current esthetics market, practitioners must obtain consistent continuing education in advanced esthetics.
The Dermatology Digest
AUGUST 12, 2024
The purchase price represents a premium of 89% over Revance’s closing market price on August 9, 2024, and a 111% premium to Revance’s 60-day volume-weighted average price. The post Breaking Business News: Crown Laboratories to Buy Revance Therapeutics in $924 Million Merger Deal appeared first on The Dermatology Digest.
The Dermatology Digest
SEPTEMBER 9, 2024
“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. Liu Yi, Sisram Chairman and Executive Director, in a news release. and Abroad appeared first on The Dermatology Digest.
Expert insights. Personalized for you.
69 
Let's personalize your content